These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 32835132)

  • 1. mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19.
    Ramaiah MJ
    Gene Rep; 2020 Sep; 20():100765. PubMed ID: 32835132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1.
    Ma-Lauer Y; Carbajo-Lozoya J; Hein MY; Müller MA; Deng W; Lei J; Meyer B; Kusov Y; von Brunn B; Bairad DR; Hünten S; Drosten C; Hermeking H; Leonhardt H; Mann M; Hilgenfeld R; von Brunn A
    Proc Natl Acad Sci U S A; 2016 Aug; 113(35):E5192-201. PubMed ID: 27519799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.
    Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP
    Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How autophagy controls the intestinal epithelial barrier.
    Foerster EG; Mukherjee T; Cabral-Fernandes L; Rocha JDB; Girardin SE; Philpott DJ
    Autophagy; 2022 Jan; 18(1):86-103. PubMed ID: 33906557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.
    Selinger M; Věchtová P; Tykalová H; Ošlejšková P; Rumlová M; Štěrba J; Grubhoffer L
    Comput Struct Biotechnol J; 2022; 20():2759-2777. PubMed ID: 35685361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway.
    Cao W; Manicassamy S; Tang H; Kasturi SP; Pirani A; Murthy N; Pulendran B
    Nat Immunol; 2008 Oct; 9(10):1157-64. PubMed ID: 18758466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling.
    Kaur S; Lal L; Sassano A; Majchrzak-Kita B; Srikanth M; Baker DP; Petroulakis E; Hay N; Sonenberg N; Fish EN; Platanias LC
    J Biol Chem; 2007 Jan; 282(3):1757-68. PubMed ID: 17114181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All hands on deck: SARS-CoV-2 proteins that block early anti-viral interferon responses.
    Setaro AC; Gaglia MM
    Curr Res Virol Sci; 2021; 2():100015. PubMed ID: 34786565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus.
    Bouvet M; Voigt S; Tagawa T; Albanese M; Chen YA; Chen Y; Fachko DN; Pich D; Göbel C; Skalsky RL; Hammerschmidt W
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An anti-interferon activity shared by paramyxovirus C proteins: inhibition of Toll-like receptor 7/9-dependent alpha interferon induction.
    Yamaguchi M; Kitagawa Y; Zhou M; Itoh M; Gotoh B
    FEBS Lett; 2014 Jan; 588(1):28-34. PubMed ID: 24269682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function.
    Schalm SS; Fingar DC; Sabatini DM; Blenis J
    Curr Biol; 2003 May; 13(10):797-806. PubMed ID: 12747827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial and temporal roles of SARS-CoV PL
    Yan S; Wu G
    FASEB J; 2021 Jan; 35(1):e21197. PubMed ID: 33368679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons.
    Lekmine F; Uddin S; Sassano A; Parmar S; Brachmann SM; Majchrzak B; Sonenberg N; Hay N; Fish EN; Platanias LC
    J Biol Chem; 2003 Jul; 278(30):27772-80. PubMed ID: 12759354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK/STAT and TGFB signaling pathways.
    Aydemir MN; Aydemir HB; Korkmaz EM; Budak M; Cekin N; Pinarbasi E
    Gene Rep; 2021 Mar; 22():101012. PubMed ID: 33398248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular parasitism with Toxoplasma gondii stimulates mammalian-target-of-rapamycin-dependent host cell growth despite impaired signalling to S6K1 and 4E-BP1.
    Wang Y; Weiss LM; Orlofsky A
    Cell Microbiol; 2009 Jun; 11(6):983-1000. PubMed ID: 19302577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
    Han S; Khuri FR; Roman J
    Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
    de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
    Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEK inhibition drives anti-viral defence in RV but not RSV challenged human airway epithelial cells through AKT/p70S6K/4E-BP1 signalling.
    Baturcam E; Vollmer S; Schlüter H; Maciewicz RA; Kurian N; Vaarala O; Ludwig S; Cunoosamy DM
    Cell Commun Signal; 2019 Jul; 17(1):78. PubMed ID: 31319869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.
    Chang CY; Liu HM; Chang MF; Chang SC
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.